| Year |
Citation |
Score |
| 2022 |
Winters BL, Lau BK, Vaughan CW. Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 42: 7744-7756. PMID 36414010 DOI: 10.1523/JNEUROSCI.0997-22.2022 |
0.69 |
|
| 2021 |
Lau BK, Murphy-Royal C, Kaur M, Qiao M, Bains JS, Gordon GR, Borgland SL. Obesity-induced astrocyte dysfunction impairs heterosynaptic plasticity in the orbitofrontal cortex. Cell Reports. 36: 109563. PMID 34407401 DOI: 10.1016/j.celrep.2021.109563 |
0.613 |
|
| 2020 |
Lau BK, Ambrose BP, Thomas CS, Qiao M, Borgland SL. Mu-opioids suppress GABAergic synaptic transmission onto orbitofrontal cortex pyramidal neurons with subregional selectivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32601247 DOI: 10.1523/Jneurosci.2049-19.2020 |
0.634 |
|
| 2020 |
Konen LM, Wright AL, Royle GA, Morris GP, Lau BK, Seow PW, Zinn R, Milham LT, Vaughan CW, Vissel B. A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability. Molecular Brain. 13: 27. PMID 32102661 DOI: 10.1186/S13041-020-0545-1 |
0.595 |
|
| 2020 |
Lau BK, Winters BL, Vaughan CW. Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway. British Journal of Pharmacology. PMID 31971607 DOI: 10.1111/bph.14982 |
0.644 |
|
| 2017 |
Lau BK, Cota D, Cristino L, Borgland SL. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology. PMID 28579186 DOI: 10.1016/J.Neuropharm.2017.05.033 |
0.646 |
|
| 2017 |
Baimel C, Lau BK, Qiao M, Borgland SL. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons. Cell Reports. 18: 1346-1355. PMID 28178514 DOI: 10.1016/J.Celrep.2017.01.030 |
0.695 |
|
| 2016 |
Aubrey KR, Drew GM, Jeong HJ, Lau BK, Vaughan CW. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses. The Journal of Physiology. PMID 27461371 DOI: 10.1113/Jp272292 |
0.614 |
|
| 2015 |
Thompson JL, Yang J, Lau B, Liu S, Baimel C, Kerr LE, Liu F, Borgland SL. Age-Dependent D1-D2 Receptor Coactivation in the Lateral Orbitofrontal Cortex Potentiates NMDA Receptors and Facilitates Cognitive Flexibility. Cerebral Cortex (New York, N.Y. : 1991). PMID 26405054 DOI: 10.1093/Cercor/Bhv222 |
0.693 |
|
| 2014 |
Lau BK, Vaughan CW. Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. Current Opinion in Neurobiology. 29: 159-64. PMID 25064178 DOI: 10.1016/j.conb.2014.07.010 |
0.655 |
|
| 2014 |
Lau BK, Drew GM, Mitchell VA, Vaughan CW. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. British Journal of Pharmacology. 171: 5225-36. PMID 25041240 DOI: 10.1111/bph.12839 |
0.599 |
|
| 2014 |
Lau BK, Vaughan CW. Targeting the endogenous cannabinoid system to treat neuropathic pain. Frontiers in Pharmacology. 5: 28. PMID 24624084 DOI: 10.3389/fphar.2014.00028 |
0.549 |
|
| 2014 |
Lau BK, Karim S, Goodchild AK, Vaughan CW, Drew GM. Menthol enhances phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey neurons. British Journal of Pharmacology. 171: 2803-13. PMID 24460753 DOI: 10.1111/Bph.12602 |
0.65 |
|
| 2009 |
Drew GM, Lau BK, Vaughan CW. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 7220-9. PMID 19494144 DOI: 10.1523/JNEUROSCI.4362-08.2009 |
0.664 |
|
| 2008 |
Lau BK, Vaughan CW. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Molecular Pharmacology. 74: 1392-8. PMID 18678620 DOI: 10.1124/mol.108.045872 |
0.654 |
|
| Show low-probability matches. |